vs
Protalix BioTherapeutics, Inc.(PLX)与High Roller Technologies, Inc.(ROLR)财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是High Roller Technologies, Inc.的1.5倍($9.1M vs $6.3M),High Roller Technologies, Inc.净利率更高(58.4% vs -60.3%,领先118.7%),High Roller Technologies, Inc.同比增速更快(-16.4% vs -49.9%),Protalix BioTherapeutics, Inc.自由现金流更多($1.6M vs $-90.0K)
Protalix BioTherapeutics是一家以色列制药企业,核心产品为植物源酶制剂他利苷酶阿尔法,该产品已获美国食品药品监督管理局批准,用于治疗戈谢病,专注于开发创新生物技术药物服务患者需求。
该企业主营游乐设施业务,凭借气动驱动技术打造各类游乐设备,专业从事过山车设计研发,在游乐设施设计制造领域拥有相关技术积累与行业经验。
PLX vs ROLR — 直观对比
营收规模更大
PLX
是对方的1.5倍
$6.3M
营收增速更快
ROLR
高出33.5%
-49.9%
净利率更高
ROLR
高出118.7%
-60.3%
自由现金流更多
PLX
多$1.7M
$-90.0K
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $9.1M | $6.3M |
| 净利润 | $-5.5M | $3.7M |
| 毛利率 | 49.4% | — |
| 营业利润率 | -51.1% | 1.3% |
| 净利率 | -60.3% | 58.4% |
| 营收同比 | -49.9% | -16.4% |
| 净利润同比 | -184.8% | 831.9% |
| 每股收益(稀释后) | $-0.06 | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PLX
ROLR
| Q4 25 | $9.1M | — | ||
| Q3 25 | $17.9M | $6.3M | ||
| Q2 25 | $15.7M | $6.9M | ||
| Q1 25 | $10.1M | $6.8M | ||
| Q4 24 | $18.2M | — | ||
| Q3 24 | $18.0M | $7.5M | ||
| Q2 24 | $13.5M | — | ||
| Q4 23 | $10.5M | — |
净利润
PLX
ROLR
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $2.4M | $3.7M | ||
| Q2 25 | $164.0K | $-592.0K | ||
| Q1 25 | $-3.6M | $-3.3M | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $3.2M | $-501.0K | ||
| Q2 24 | $-2.2M | — | ||
| Q4 23 | $-6.0M | — |
毛利率
PLX
ROLR
| Q4 25 | 49.4% | — | ||
| Q3 25 | 53.4% | — | ||
| Q2 25 | 62.5% | — | ||
| Q1 25 | 19.1% | — | ||
| Q4 24 | 78.7% | — | ||
| Q3 24 | 53.4% | — | ||
| Q2 24 | 29.8% | — | ||
| Q4 23 | 15.5% | — |
营业利润率
PLX
ROLR
| Q4 25 | -51.1% | — | ||
| Q3 25 | 11.9% | 1.3% | ||
| Q2 25 | 7.5% | -7.2% | ||
| Q1 25 | -41.0% | -47.4% | ||
| Q4 24 | 39.6% | — | ||
| Q3 24 | 22.2% | -6.3% | ||
| Q2 24 | -18.0% | — | ||
| Q4 23 | -53.5% | — |
净利率
PLX
ROLR
| Q4 25 | -60.3% | — | ||
| Q3 25 | 13.2% | 58.4% | ||
| Q2 25 | 1.0% | -8.5% | ||
| Q1 25 | -35.8% | -48.4% | ||
| Q4 24 | 35.6% | — | ||
| Q3 24 | 18.0% | -6.7% | ||
| Q2 24 | -16.4% | — | ||
| Q4 23 | -57.6% | — |
每股收益(稀释后)
PLX
ROLR
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.03 | $0.39 | ||
| Q2 25 | $0.00 | $-0.07 | ||
| Q1 25 | $-0.05 | $-0.39 | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.03 | $-0.07 | ||
| Q2 24 | $-0.03 | — | ||
| Q4 23 | $-0.03 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $2.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.2M | $6.6M |
| 总资产 | $82.3M | $16.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
PLX
ROLR
| Q4 25 | $14.7M | — | ||
| Q3 25 | $13.6M | $2.7M | ||
| Q2 25 | $17.9M | $2.7M | ||
| Q1 25 | $19.5M | $3.5M | ||
| Q4 24 | $19.8M | — | ||
| Q3 24 | $27.4M | $1.3M | ||
| Q2 24 | $23.4M | — | ||
| Q4 23 | $23.6M | — |
股东权益
PLX
ROLR
| Q4 25 | $48.2M | — | ||
| Q3 25 | $52.9M | $6.6M | ||
| Q2 25 | $49.9M | $2.6M | ||
| Q1 25 | $45.2M | $2.8M | ||
| Q4 24 | $43.2M | — | ||
| Q3 24 | $32.4M | $-779.0K | ||
| Q2 24 | $28.6M | — | ||
| Q4 23 | $33.6M | — |
总资产
PLX
ROLR
| Q4 25 | $82.3M | — | ||
| Q3 25 | $82.3M | $16.0M | ||
| Q2 25 | $78.5M | $12.3M | ||
| Q1 25 | $73.9M | $12.8M | ||
| Q4 24 | $73.4M | — | ||
| Q3 24 | $61.6M | $12.9M | ||
| Q2 24 | $91.5M | — | ||
| Q4 23 | $84.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $2.0M | $-78.0K |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $-90.0K |
| 自由现金流率自由现金流/营收 | 17.8% | -1.4% |
| 资本支出强度资本支出/营收 | 4.4% | 0.2% |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | $-13.6M | — |
8季度趋势,按日历期对齐
经营现金流
PLX
ROLR
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-3.7M | $-78.0K | ||
| Q2 25 | $-5.2M | $-840.0K | ||
| Q1 25 | $-5.1M | $-3.6M | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | $4.1M | — | ||
| Q2 24 | $-3.6M | — | ||
| Q4 23 | $3.6M | — |
自由现金流
PLX
ROLR
| Q4 25 | $1.6M | — | ||
| Q3 25 | $-4.2M | $-90.0K | ||
| Q2 25 | $-5.7M | $-845.0K | ||
| Q1 25 | $-5.4M | $-3.6M | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $4.0M | — | ||
| Q2 24 | $-3.8M | — | ||
| Q4 23 | $3.3M | — |
自由现金流率
PLX
ROLR
| Q4 25 | 17.8% | — | ||
| Q3 25 | -23.7% | -1.4% | ||
| Q2 25 | -36.2% | -12.2% | ||
| Q1 25 | -53.0% | -53.5% | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 22.4% | — | ||
| Q2 24 | -28.1% | — | ||
| Q4 23 | 31.9% | — |
资本支出强度
PLX
ROLR
| Q4 25 | 4.4% | — | ||
| Q3 25 | 2.8% | 0.2% | ||
| Q2 25 | 2.8% | 0.1% | ||
| Q1 25 | 3.0% | 0.2% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 1.3% | — | ||
| Q4 23 | 2.4% | — |
现金转化率
PLX
ROLR
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | -0.02× | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
ROLR
| Net Gaming Revenue | $4.9M | 77% |
| Net Revenue Noncore Services | $1.4M | 23% |